Halkia E.,Peritoneal Surface Malignancy Unit |
Gavriel S.,Peritoneal Surface Malignancy Unit |
Gavriel S.,IASO General Hospital |
Spiliotis J.,Metaxa Cancer Hospital
Journal of B.U.ON. | Year: 2014
Peritoneal carcinomatosis (PC) is a condition that has been associated with poor outcomes and up until recently was considered a terminal condition. However, recent data suggest that cytoreductive surgery (CRS) and the administration of hyperthermic intraperitoneal chemotherapy (HIPEC) is an effective therapeutic approach. This paper is a review of the recent literature regarding this issue.